Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy

Trial Profile

Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy

Status: Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 26 Oct 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs NFL 101 (Primary)
  • Indications Smoking withdrawal
  • Focus Registrational; Therapeutic Use
  • Acronyms CESTO2
  • Sponsors Smoke Free Therapeutics
  • Most Recent Events

    • 22 Oct 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
    • 22 Oct 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Jul 2024.
    • 20 Feb 2023 According to a NFL BIOSCIENCES media release, to complete the CESTO II clinical study designed to evaluate the efficacy and safety of its NFL-101 treatment as a smoking cessation therapy, NFL Biosciences has been granted an innovation advance of dollar 1,500,000 as part of the Programme dInvestissement dAvenir 4 of the France 2030 plan.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top